Intelligence Feed event · Policy · 2026-09-09

    Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and F-35 Backlog

    Question

    Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and F-35 Backlog

    Direct answer

    UBS lifted Lockheed Martin (LMT) to a Buy rating, pointing to structural backlog conversion across tactical aircraft and precision munitions. The brokerage highlighted the firm's 3.2x book-to-bill ratio as an indicator of durable revenue momentum spanning the next 24 to 36 months. The forecast projects 9% annual sales growth coupled with double-digit EPS gains. Trading under 14x free cash flow, the stock offers defensive cash flow characteristics amid broader equity market volatility.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-09
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and F-35 Backlog”, revision 1, evidence through 2026-09-09. https://marketontology.com/market-events/2026-09-09/lockheed-martin-upgraded-to-buy-at-ubs-on-3-2x-book-to-bill-and-f-35-backlog-da270a

    POLICY
    Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and F-35 Backlog
    UBS lifted Lockheed Martin (LMT) to a Buy rating, pointing to structural backlog conversion across tactical aircraft and precision munitions. The brokerage highlighted the firm's 3.2x book-to-bill ratio as an indicator of durable revenue momentum spanning the next 24 to 36 months. The forecast projects 9% annual sales growth coupled with double-digit EPS gains. Trading under 14x free cash flow, the stock offers defensive cash flow characteristics amid broader equity market volatility.
    LMTITA
    Impact
    72
    SEP 9
    SIG
    88%
    LMTITA
    Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and F-35 Backlog
    UBS lifted Lockheed Martin (LMT) to a Buy rating, pointing to structural backlog conversion across tactical aircraft and precision munitions. The brokerage highlighted the firm's 3.2x book-to-bill ratio as an indicator of durable revenue momentum spanning the next 24 to 36 months. The forecast projects 9% annual sales growth coupled with double-digit EPS gains. Trading under 14x free cash flow, the stock offers defensive cash flow characteristics amid broader equity market volatility.
    → A 3.2x book-to-bill backlog secures multi-year cash flow visibility, driving P/E multiple rerating toward 21x for LMT against aerospace peers.
    Impact
    UBS lifted Lockheed Martin (LMT) to a Buy rating, pointing to structural backlog conversion across tactical aircraft and precision munitions. The brokerage highlighted the firm's 3.2x book-to-bill ratio as an indicator of durable revenue momentum spanning the next 24 to 36 months. The forecast projects 9% annual sales growth coupled with double-digit EPS gains. Trading under 14x free cash flow, the stock offers defensive cash flow characteristics amid broader equity market volatility.
    Affected
    LMTITA
    Transmission
    A 3.2x book-to-bill backlog secures multi-year cash flow visibility, driving P/E multiple rerating toward 21x for LMT against aerospace peers.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    LMTbrokerage upgrade driving institutional allocation into aerospace and defenseUp1-5dUBS upgraded LMT to Buy citing 3.2x book-to-bill ratio and 9% sales growth outlook.
    ITAdefense prime constituent weighting lift across US aerospace ETFUp1-5dLMT represents a core weighting in US aerospace and defense benchmark indices.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    ITAUpdisagreed219.45 2026-09-09-0.51%-1.90%-7.22%
    LMTUpdisagreed524.46 2026-09-09+1.08%+2.44%-4.81%

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month